Literature DB >> 18075501

Non-traditional risk factors predict coronary calcification in chronic kidney disease in a population-based cohort.

U Baber1, J A de Lemos, A Khera, D K McGuire, T Omland, R D Toto, S S Hedayati.   

Abstract

The increased burden of cardiovascular disease in chronic kidney disease cannot be explained by traditional risk factors alone. Here, we evaluated the impact of non-traditional factors on the association of chronic kidney disease with coronary artery calcification using logistic regression among 2672 Dallas Heart Study patients of whom 220 had chronic kidney disease. The prevalence of coronary calcification significantly increased across all chronic kidney disease stages and this remained independently associated with coronary calcification after adjusting for traditional factors. The calcium x phosphorus product, homocysteine, and osteoprotegerin each diminished the magnitude of association between kidney disease and coronary calcification. After adjustment for these, the association between kidney disease and coronary calcification was no longer significant with the effects most prominent in the stages 3-5 subgroup. Our study has identified three non-traditional independent predictors of coronary calcification that diminished the association between chronic kidney disease and coronary calcification. These factors may represent novel mechanistic links warranting further investigation.

Entities:  

Mesh:

Year:  2007        PMID: 18075501     DOI: 10.1038/sj.ki.5002716

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  21 in total

1.  Kidney function and risk of cardiovascular disease and mortality in kidney transplant recipients: the FAVORIT trial.

Authors:  D E Weiner; M A Carpenter; A S Levey; A Ivanova; E H Cole; L Hunsicker; B L Kasiske; S J Kim; J W Kusek; A G Bostom
Journal:  Am J Transplant       Date:  2012-05-17       Impact factor: 8.086

2.  Racial Differences in Natriuretic Peptide Levels: The Dallas Heart Study.

Authors:  Deepak K Gupta; James A de Lemos; Colby R Ayers; Jarett D Berry; Thomas J Wang
Journal:  JACC Heart Fail       Date:  2015-06-10       Impact factor: 12.035

3.  Osteopontin: an emerging therapeutic target in uraemic vascular disease.

Authors:  Xin Zhang; Alfonso Eirin; Amir Lerman; Lilach O Lerman
Journal:  Cardiovasc Res       Date:  2013-04-23       Impact factor: 10.787

Review 4.  Mineral and bone disorders in children with chronic kidney disease.

Authors:  Claus Peter Schmitt; Otto Mehls
Journal:  Nat Rev Nephrol       Date:  2011-09-27       Impact factor: 28.314

Review 5.  Utility of traditional circulating and imaging-based cardiac biomarkers in patients with predialysis CKD.

Authors:  Gates Colbert; Nishank Jain; James A de Lemos; S Susan Hedayati
Journal:  Clin J Am Soc Nephrol       Date:  2014-11-17       Impact factor: 8.237

6.  Association of Monocyte Chemoattractant Protein-1 with Death and Atherosclerotic Events in Chronic Kidney Disease.

Authors:  L Parker Gregg; Maria Clarissa Tio; Xilong Li; Beverley Adams-Huet; James A de Lemos; S Susan Hedayati
Journal:  Am J Nephrol       Date:  2018-06-06       Impact factor: 3.754

7.  Coronary calcification in patients with chronic kidney disease and coronary artery disease.

Authors:  Satoko Nakamura; Hatsue Ishibashi-Ueda; Sinichiro Niizuma; Fumiki Yoshihara; Takeshi Horio; Yuhei Kawano
Journal:  Clin J Am Soc Nephrol       Date:  2009-10-15       Impact factor: 8.237

Review 8.  Cardiovascular risk factors in patients with chronic kidney disease.

Authors:  Sarina van der Zee; Usman Baber; Sammy Elmariah; Jonathan Winston; Valentin Fuster
Journal:  Nat Rev Cardiol       Date:  2009-07-21       Impact factor: 32.419

Review 9.  Calcification in atherosclerosis.

Authors:  Nikolaos Alexopoulos; Paolo Raggi
Journal:  Nat Rev Cardiol       Date:  2009-09-29       Impact factor: 32.419

10.  Risk factors for coronary artery calcium among patients with chronic kidney disease (from the Chronic Renal Insufficiency Cohort Study).

Authors:  Jiang He; Muredach Reilly; Wei Yang; Jing Chen; Alan S Go; James P Lash; Mahboob Rahman; Chris DeFilippi; Crystal Gadegbeku; Radhika Kanthety; Kaixiang Tao; L Lee Hamm; Akinlolu Ojo; Ray Townsend; Matthew Budoff
Journal:  Am J Cardiol       Date:  2012-09-14       Impact factor: 2.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.